{"id":"W2560526418","doi":"10.1200/jco.2011.29.7_suppl.304","title":"Everolimus in metastatic renal cell carcinoma (mRCC): Subgroup analysis of patients (pts) with one versus two prior vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) therapies enrolled in the phase III RECORD-1 study.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Everolimus; Medicine; Hazard ratio; Sorafenib; Sunitinib; Internal medicine; Placebo; Renal cell carcinoma; Oncology; Gastroenterology; Urology; Confidence interval; Hepatocellular carcinoma; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001505065,0.0006185981,0.002145495,0.0005301696,0.0002823459,0.0007180192,0.0004654368,0.0009994445,0.001964887],"category_scores_gemma":[0.001894165,0.0003337233,0.004612654,0.0005894431,0.0002901451,0.0004943911,0.0004759035,0.0007955362,0.0002319786],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004185335,"about_ca_system_score_gemma":0.0005572883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001216958,"about_ca_topic_score_gemma":0.002391822,"domain_scores_codex":[0.9990479,0.0003822178,0.0001160845,0.0002530262,0.00009349094,0.0001072451],"domain_scores_gemma":[0.9990826,0.0003625862,0.0002297906,0.0001016239,0.00003957143,0.0001839259],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6273577,0.0015689,0.310472,0.0008534509,0.0300052,0.0007125054,0.0001927939,0.001058944,0.007231462,0.0001017393,0.001125668,0.01931971],"study_design_scores_gemma":[0.08455555,0.06158635,0.8118472,0.0001526522,0.03071644,0.0014831,0.0005421297,0.004228568,0.002008874,0.0004438006,0.002327254,0.0001080625],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971247,0.00188853,0.0001168516,0.00007505016,0.00003828525,0.00009134156,0.0004515244,0.000005093666,0.0002086276],"genre_scores_gemma":[0.9985331,0.0003404335,0.0000971983,0.000084988,0.00005671716,0.00007503699,0.0006221026,0.00000369678,0.0001868233],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002145495,"threshold_uncertainty_score":0.007959604,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1116955388678151,"score_gpt":0.3780380342279233,"score_spread":0.2663424953601081,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}